13F filer · CIK 1422848 ↗
Capital Research Global Investors
You are looking at Q2 2023. See the latest, Q2 2026 →
Reported value
$373.18B
+6.5% on the quarter before
Positions
414
22 new · 33 sold out
Top 10
28.5%
of the value
Est. gain
+$25.89B
on stocks held all quarter
Est. return
+8.1%
on those stocks since Q1 2023
Positions as of Jun 30, 2023, from Capital Research Global Investors's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 45% of the reported value, each sized by its share, colored by what the fund did with it since Q1 2023. Striped tiles are options.
Largest buys
Since Q1 2023, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Texas Instruments~$1.94BAdded · 0.3% → 0.8%+10,775,119 shares
- Marvell Technology Inc~$1.94BAdded · 0.0% → 0.5%+32,387,593 shares
- Adobe~$1.84BAdded · 0.0% → 0.5%+3,769,125 shares
- Celanese Corp Del~$1.15BAdded · 0.0% → 0.3%+9,926,210 shares
- Capital One Finl Corp~$874.9MNew · 0.0% → 0.2%+7,999,882 shares
- Cenovus Energy Inc~$864.9MAdded · 0.5% → 0.7%+50,921,845 shares
- Alphabet~$810.2MAdded · 1.3% → 1.6%+6,768,837 shares
- Vertex Pharmaceuticals Inc~$792.4MAdded · 0.1% → 0.3%+2,251,781 shares
- Home Depot Inc~$741.9MAdded · 0.9% → 1.1%+2,388,281 shares
- Intel~$696.8MAdded · 0.5% → 0.7%+20,836,219 shares
Largest sells
Since Q1 2023, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Meta~$2.30BCut · 1.8% → 1.7%−8,002,955 shares
- Broadcom~$1.70BCut · 3.9% → 4.5%−1,961,728 shares
- D R Horton Inc~$1.40BCut · 0.7% → 0.5%−11,501,600 shares
- General Electric Co~$1.29BCut · 2.8% → 2.7%−11,755,741 shares
- Micron~$1.22BCut · 1.2% → 0.9%−19,290,654 shares
- Applied Materials~$911.4MSold out · 0.3% → 0.0%−7,419,646 shares
- Shopify Inc~$909.1MCut · 0.8% → 0.8%−14,073,196 shares
- Comcast Corp New~$871.1MCut · 1.3% → 1.1%−20,965,438 shares
- Keurig Dr Pepper Inc~$817.9MCut · 0.3% → 0.0%−26,156,234 shares
- Teva Pharmaceutical Inds Ltd~$731.4MSold out · 0.2% → 0.0%−82,644,367 shares
Holdings
As of Jun 30, 2023. Changes are in shares against Mar 31, 2023, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MicrosoftCOM · shares −2.2% · price +18.1% | 6.7% | $25.01B | +$3.84B | ||||||||
| BroadcomCOM · shares −9.3% · price +35.2% | 4.5% | $16.66B | +$4.34B | ||||||||
| AmazonCOM · shares +4.2% · price +26.2% | 3.4% | $12.79B | +$2.55B | ||||||||
| General Electric CoCOM NEW · shares −11% · price +14.9% | 2.7% | $10.17B | +$1.32B | ||||||||
| Abbott LabsCOM · shares +1.1% · price +7.7% | 2.3% | $8.42B | +$592.9M | ||||||||
| NetflixCOM · shares −7.5% · price +27.5% | 2.1% | $7.70B | +$1.66B | ||||||||
| Unitedhealth Group IncCOM · shares −3.2% · price +1.7% | 1.9% | $6.92B | +$115.9M | ||||||||
| Raytheon Technologies CorpCOM · shares −9.7% · price +0.0% | 1.7% | $6.52B | +$2.0M | ||||||||
| MetaCL A · shares −27% · price +35.4% | 1.7% | $6.25B | +$1.63B | ||||||||
| AlphabetCAP STK CL A · shares +16% · price +15.4% | 1.6% | $5.93B | +$683.5M | ||||||||
| MastercardCL A · shares −9.0% · price +8.2% | 1.5% | $5.72B | +$434.4M | ||||||||
| Canadian Nat Res LtdCOM · shares −11% · price +1.6% | 1.4% | $5.18B | +$81.4M | ||||||||
| Philip Morris Intl IncCOM · shares +4.9% · price +0.4% | 1.3% | $5.03B | +$18.2M | ||||||||
| Linde PlcSHS · shares −0.4% · price +7.2% | 1.2% | $4.59B | +$308.6M | ||||||||
| Gilead Sciences IncCOM · shares −0.6% · price −7.1% | 1.2% | $4.46B | −$341.6M | ||||||||
| AppleCOM · shares −1.0% · price +17.6% | 1.2% | $4.43B | +$663.3M | ||||||||
| Abbvie IncCOM · shares −8.9% · price −15.5% | 1.2% | $4.38B | −$801.9M | ||||||||
| Stryker CorporationCOM · shares −10% · price +6.9% | 1.2% | $4.38B | +$281.6M | ||||||||
| Carrier GlobalCOM · shares +7.9% · price +8.7% | 1.1% | $4.13B | +$305.2M | ||||||||
| Comcast Corp NewCL A · shares −18% · price +9.6% | 1.1% | $4.08B | +$357.6M | ||||||||
| AlphabetCAP STK CL C · shares +3.9% · price +16.3% | 1.1% | $4.08B | +$550.7M | ||||||||
| GE HealthCareCOMMON STOCK · shares +14% · price −1.0% | 1.1% | $4.03B | −$34.3M | ||||||||
| Home Depot IncCOM · shares +23% · price +5.3% | 1.1% | $3.99B | +$162.2M | ||||||||
| Eog Res IncCOM · shares +11% · price −0.2% | 1.0% | $3.88B | −$5.8M | ||||||||
| NvidiaCOM · shares −5.1% · price +52.3% | 0.96% | $3.58B | +$1.23B | ||||||||
| Total · 414 positions | 100% | $373.18B | +$25.89B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q1 2023 to Q2 2023: 391 stocks held throughout, up $25.89B (+8.1%).
- Broadcom+$4.34B+35%
- Microsoft+$3.84B+18%
- Amazon+$2.55B+26%
- Netflix+$1.66B+27%
- Meta+$1.63B+35%
- Gilead Sciences Inc−$341.6M−7%
- MercadoLibre−$345.0M−10%
- EPAM Systems−$507.9M−25%
- Abbvie Inc−$801.9M−15%
- Sea−$1.05B−33%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 2 splits read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 12, 2026 | $716.87B+11% | SEC ↗ |
| Q1 2026 | May 13, 2026 | $644.56B+19% | SEC ↗ |
| Q4 2025 | Feb 11, 2026 | $541.73B+2% | SEC ↗ |
| Q3 2025 | Nov 13, 2025 | $532.97B+7% | SEC ↗ |
| Q2 2025 | Aug 13, 2025 | $499.46B+9% | SEC ↗ |
| Q1 2025 | May 12, 2025 | $459.90B−5% | SEC ↗ |
| Q4 2024 | Feb 13, 2025 | $486.38B+1% | SEC ↗ |
| Q3 2024 | Nov 13, 2024 | $481.14B+6% | SEC ↗ |
| Q2 2024 | Aug 13, 2024 | $455.74B+3% | SEC ↗ |
| Q1 2024 | May 14, 2024 | $441.98B+9% | SEC ↗ |
| Q4 2023 | Feb 13, 2024 | $406.47B+12% | SEC ↗ |
| Q3 2023 | Nov 13, 2023 | $363.16B−3% | SEC ↗ |
| Q2 2023 | Aug 11, 2023 | $373.18B+7% | SEC ↗ |
| Q1 2023 | May 15, 2023 | $350.40B+6% | SEC ↗ |
| Q4 2022 | Feb 14, 2023 | $330.88B+9% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $304.37B−5% | SEC ↗ |
| Q2 2022 | Aug 15, 2022 | $321.05B−21% | SEC ↗ |
| Q1 2022 | May 19, 2022 (amended) | $405.10B−11% | SEC ↗ |
| Q4 2021 | Feb 14, 2022 | $452.67B+6% | SEC ↗ |
| Q3 2021 | Nov 15, 2021 | $428.65B−0% | SEC ↗ |
| Q2 2021 | Aug 16, 2021 | $429.52B+5% | SEC ↗ |
| Q1 2021 | May 14, 2021 | $408.71B+6% | SEC ↗ |
| Q4 2020 | Feb 12, 2021 | $385.30B+16% | SEC ↗ |
| Q3 2020 | Nov 13, 2020 | $333.11B+5% | SEC ↗ |
| Q2 2020 | Aug 14, 2020 | $316.13B+24% | SEC ↗ |
| Q1 2020 | May 15, 2020 | $254.90B−24% | SEC ↗ |
| Q4 2019 | Feb 18, 2020 | $333.48B+9% | SEC ↗ |
| Q3 2019 | Nov 14, 2019 | $304.85B−3% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $314.99B−0% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $315.45B+10% | SEC ↗ |
| Q4 2018 | Feb 14, 2019 | $287.02B−17% | SEC ↗ |
| Q3 2018 | Nov 14, 2018 | $344.02B−6% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $366.12B+4% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $351.43B+3% | SEC ↗ |
| Q4 2017 | Feb 14, 2018 | $340.76B+3% | SEC ↗ |
| Q3 2017 | Nov 14, 2017 | $331.24B+4% | SEC ↗ |
| Q2 2017 | Aug 14, 2017 | $319.49B+1% | SEC ↗ |
| Q1 2017 | May 15, 2017 | $317.04B+3% | SEC ↗ |
| Q4 2016 | Feb 15, 2017 | $308.47B+2% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $302.53B+3% | SEC ↗ |
| Q2 2016 | Aug 15, 2016 | $292.47B+1% | SEC ↗ |
| Q1 2016 | May 16, 2016 | $290.06B | SEC ↗ |